Mustafa Çelik

Mustafa Çelik

Liv Hospital Content Team
...
Views
Read Time
SEP 15072 image 1 LIV Hospital
Stage 0 Breast Cancer: Amazing Recovery News 4


When it comes to beating breast cancer, the type and stage matter a lot. People often wonder, “Is breast cancer curable?” The answer is yes, but it depends on catching it early and the cancer‘s type. Hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer is usually the most treatable.

Recent studies show that the 5-year survival rate for HR+/HER2- breast cancer is about 95.6% for all cases. For cases that are caught early, the survival rate is 100%. At Liv Hospital, we’re working hard to improve breast cancer care. We aim to deliver top-notch results and keep getting better at our services.

Stage 0 breast cancer offers amazing recovery odds. Learn about the miraculous survival rates and why this is the easiest stage to treat and beat.

Key Takeaways

  • HR+/HER2- breast cancer is considered one of the most treatable forms.
  • Early detection significantly improves treatment outcomes.
  • Liv Hospital offers world-class care with innovative medical protocols.
  • The 5-year relative survival rate for HR+/HER2- is around 95.6%.
  • Localized disease has a 100% 5-year relative survival rate.

Understanding Breast Cancer Survival Rates

Learning about breast cancer survival rates is key for patients and doctors. These rates help us understand how well treatments work. They also tell us what to expect for patients with breast cancer.

How Survival Rates Are Measured

Survival rates for breast cancer are usually based on the 5-year relative survival rate. This rate shows how many patients live for 5 years after being diagnosed. The SEER data says that women with early breast cancer have a 99% chance of surviving 5 years.

“The 5-year survival rate is a key indicator,” says a top oncologist. It lets us compare how well treatments work for differe<SEP-15072_image_2>nt patients and stages of cancer.

Factors That Influence Survival Statistics

Many things affect breast cancer survival rates. These include the cancer’s stage, type, and the patient’s health. For example, early-stage cancers like stage 0 or stage 1 have much higher survival rates.

  • Stage at Diagnosis: Finding cancer early greatly improves chances of survival. Stage 0 and stage 1 cancers have high survival rates because of effective treatments.
  • Type of Breast Cancer: The type of breast cancer, like hormone receptor-positive or HER2-negative, affects how well it responds to treatment.
  • Patient’s Overall Health: A patient’s health before cancer can affect their ability to get certain treatments. This can change survival rates.

The 5-year survival rate for all breast cancers is about 91%. But, early-stage breast cancer has a 99% survival rate. Knowing these numbers helps both patients and doctors make better choices.

Hormone Receptor-Positive, HER2-Negative Breast Cancer: The Most Treatable Type

SEP 15072 image 2 LIV Hospital
Stage 0 Breast Cancer: Amazing Recovery News 5

Hormone receptor-positive, HER2-negative breast cancer is very treatable. It has hormone receptors and no HER2 protein. This makes it easier to fight.

This type of cancer is treatable because of its biology. Hormone receptors let doctors use endocrine therapy. This therapy slows down the cancer cells.

What Makes HR+/HER2- Breast Cancer More Treatable

Several things make HR+/HER2- breast cancer treatable. Hormone receptors make it respond well to hormone therapy. This therapy can lower the chance of the cancer coming back.

Also, not having HER2 means the cancer grows less aggressively. It doesn’t need treatments for HER2. This makes it less likely to be very aggressive.

“The responsiveness of HR+/HER2- breast cancers to hormone therapy, combined with their generally less aggressive nature compared to other subtypes like triple-negative or HER2-positive breast cancers, contributes to their more favorable prognosis.”

Treatment Response Rates and Outcomes

Research shows that HR+/HER2- breast cancer responds well to treatment. Hormone therapy works well for this type. It improves survival rates and lowers the chance of the cancer coming back.

Treatment Modality

Response Rate

5-Year Survival Rate

Hormone Therapy Alone

70-80%

90-95%

Hormone Therapy + Chemotherapy

80-90%

95-98%

These numbers show how important it is to know the cancer type. For stage 1 breast cancer, knowing the subtype helps plan treatment. This might include surgery, hormone therapy, or a mix of treatments.

For invasive ductal carcinoma grade 1, the outlook is good. It’s often in the HR+/HER2- category. This low-grade cancer responds well to treatment.

Stage0 Breast Cancer: Prognosis and Treatment


SEP 15072 image 3 LIV Hospital
Stage 0 Breast Cancer: Amazing Recovery News 6

Stage 0 breast cancer, also known as ductal carcinoma in situ (DCIS), is a condition where cancer cells are found inside some of the ducts. It hasn’t invaded the surrounding breast tissue. This early-stage cancer is considered non-invasive.

Defining Stage 0 (Ductal Carcinoma In Situ)

Ductal carcinoma in situ (DCIS) is a condition where abnormal cells are found in the milk ducts of the breast. It’s the earliest form of breast cancer and is often found during mammography. DCIS is not life-threatening but can turn into invasive cancer if not treated.

Key characteristics of DCIS include:

  • Abnormal cells are confined to the milk ducts.
  • No invasion into the surrounding breast tissue.
  • Often detected through mammography.

Treatment Options for Stage 0 Breast Cancer

Treatment for stage 0 breast cancer aims to remove abnormal cells to prevent invasive cancer. The main treatments are:

  1. Lumpectomy followed by radiation therapy to remove any remaining abnormal cells.
  2. Mastectomy in cases where the DCIS is widespread or if the patient prefers this option.

The choice of treatment depends on several factors. These include the extent of the DCIS, patient preference, and overall health.

Long-term Survival Rates

The prognosis for stage 0 breast cancer is excellent. The 5-year relative survival rate is nearly 100%. This high survival rate is thanks to effective treatments that prevent invasive cancer.

It’s important for patients with DCIS to follow their treatment plan and attend regular follow-ups. This helps monitor for any signs of recurrence or new cancers.

Stage1 Breast Cancer: Early Detection and Outcomes

Early detection is key, and stage 1 breast cancer has a good outlook. Finding breast cancer early greatly boosts treatment success and survival chances.

Characteristics of Stage 1 Breast Cancer

Stage 1 breast cancer has a small tumor, usually under 2 centimeters. It stays within the breast tissue. It’s split into Stage 1A and Stage 1B based on tumor size and lymph node involvement.

Early detection comes from regular screenings and knowing the signs. These include a new lump or thickening in the breast.

Treatment Approaches for Stage 1

Treatment for stage 1 breast cancer combines surgery, radiation, and sometimes hormone or chemotherapy. The aim is to remove the cancer and stop it from coming back.

  • Surgery: Lumpectomy or mastectomy may be done to take out the tumor and some tissue.
  • Radiation Therapy: Often needed after lumpectomy to kill any cancer cells left.
  • Hormone Therapy: Used for tumors that grow in response to hormones to lower recurrence risk.

Survival Statistics for Stage 1 Breast Cancer

The 5-year survival rate for stage 1 breast cancer is about 99%, according to SEER data. This shows how vital early detection and modern treatments are.

Stage

5-Year Relative Survival Rate

Treatment Approaches

Stage 1A

99%

Surgery, Radiation Therapy, Hormone Therapy

Stage 1B

98%

Surgery, Radiation Therapy, Chemotherapy

These numbers show the good results from catching and treating breast cancer early. We stress the need for regular screenings and knowing the signs to boost survival rates.

The Critical Importance of Early Detection

Early detection is key to beating breast cancer. Finding breast cancer early means better treatment chances and survival rates. Regular screenings and self-checks are essential.

Screening Recommendations by Age Group

Screening advice changes with age. Women usually start mammograms between 40 and 50, based on risk and health guidelines. For example, the American Cancer Society suggests starting yearly mammograms at 45 for average-risk women. Those at higher risk might start earlier.

  • Women aged 40-44 can choose annual mammograms.
  • Women aged 45-54 should get annual mammograms.
  • Women 55 and older can switch to biennial mammograms or keep annual screenings.

Self-Examination Techniques

Self-exams are also important for early detection. Women should know their breast’s normal look and feel to spot changes. Do self-exams monthly, a few days after your period.

To do a self-exam:

  1. Stand in front of a mirror and check for shape or size changes in your breasts.
  2. Lie down and feel your breasts with your opposite hand, looking for lumps or thickening.
  3. Stand up and feel your breasts again, using soapy hands in the shower for easier skin feeling.

When to Seek Medical Attention

If you find any unusual changes, like a new lump or nipple discharge, see a doctor right away. Early check-ups can offer peace of mind and timely treatment if needed.

Don’t wait if you see any first signs of breast cancer:

  • A lump or thickening in the breast or underarm area.
  • Changes in the size or shape of the breast.
  • Dimpling or puckering of the skin.
  • Nipple discharge or changes in the nipple position.

By focusing on breast health and early detection, we can improve treatment success and save lives.

First Signs of Breast Cancer: What to Watch For

Knowing the early signs of breast cancer is key for quick medical help. Spotting these signs early can lead to better treatment results. We’ll cover the common signs and how to tell if they’re serious.

Common Physical Symptoms

Breast cancer can show up in different ways. Some common signs include:

  • A new lump or thickening in the breast or underarm area
  • Changes in the size or shape of the breast
  • Dimpling or puckering of the skin
  • Nipple discharge or tenderness
  • Redness or scaliness of the nipple or breast skin

Many of these symptoms can also be from non-cancerous issues. But, if you see any changes, see a doctor right away.

Non-Physical Warning Signs

There are also signs that aren’t physical. These include:

  • Unexplained pain in the breast or armpit
  • A feeling of discomfort or unease in the breast area

These symptoms can be hard to pinpoint but might be linked to cancer. If you’re feeling a lot of pain or discomfort, talk to your doctor.

Differentiating Benign vs. Cancerous Changes

Not every breast change is cancer. Many are benign, like cysts or fibroadenomas. To tell if a change is serious, look at these points:

  • Persistence: Cancerous lumps stay the same, while benign ones might change with your cycle.
  • Pain: Both can hurt, but cancerous lumps usually don’t.
  • Changes over time: Watch for changes in size, shape, or texture. Cancerous changes grow.

If you’re not sure about a breast change, see a doctor. Early detection is critical for treating breast cancer well.

Invasive vs. Non-Invasive Breast Cancer: Understanding the Difference

Knowing the difference between invasive and non-invasive breast cancer is key to finding the right treatment. Breast cancer falls into these two types based on if the cancer cells have spread to other breast tissue.

Defining Invasive Ductal Carcinoma

Invasive ductal carcinoma (IDC) is the most common breast cancer, making up about 80% of cases. It starts in the milk ducts, breaks through the walls, and invades the fatty tissue. It can then spread to other parts of the body through the lymphatic system or bloodstream. IDC is called invasive because it invades tissues beyond the ducts or lobules.

We will explore IDC in more detail, including its grading and how it impacts treatment choices. The grade of IDC is critical in determining the prognosis and treatment plan.

Invasive Ductal Carcinoma Grade 1 Prognosis

IDC is graded from 1 to 3 based on how much the cancer cells look like normal breast cells under a microscope. Grade 1 IDC means the cancer cells are well-differentiated, closely resembling normal cells, and tend to grow and spread more slowly than higher-grade cancers. Patients with grade 1 IDC generally have a more favorable prognosis compared to those with higher-grade cancers.

  • Grade 1 IDC is considered low grade.
  • It has a relatively better prognosis.
  • Treatment often involves surgery, possibly followed by radiation therapy or hormone therapy, depending on the cancer’s characteristics and the patient’s overall health.

Non-Invasive Breast Cancers and Their Outcomes

Non-invasive breast cancer, also known as in situ cancer, is confined to the milk ducts or lobules and has not invaded surrounding tissues. The most common type is ductal carcinoma in situ (DCIS). Non-invasive cancers are typically detected during mammography and have an excellent prognosis because they are contained and usually treatable with surgery alone.

Outcomes for non-invasive breast cancers are generally very good, with high survival rates when appropriately treated. Treatment may involve:

  1. Lumpectomy followed by radiation therapy.
  2. Mastectomy in some cases.
  3. Active surveillance in select cases, though less common.

We know that a breast cancer diagnosis, whether invasive or non-invasive, can be overwhelming. But understanding the specific type and stage of cancer is the first step towards making informed decisions about treatment and care.

Treatment Timeline for Early-Stage Breast Cancer

Knowing the treatment timeline helps patients prepare and make informed decisions. Early-stage breast cancer involves a complex journey from diagnosis to follow-up. It includes many steps.

Initial Diagnosis to Treatment Planning

After diagnosis, a team of healthcare experts creates a treatment plan. This team includes surgeons, oncologists, and more. They first do staging tests to see how far the cancer has spread.

Key steps during this phase include:

  • Biopsy results analysis
  • Imaging tests (e.g., mammography, ultrasound, MRI)
  • Staging evaluations to assess cancer spread
  • Consultations with various specialists

Stage 1 Breast Cancer Treatment Timeline

For Stage 1 breast cancer, treatment starts a few weeks after diagnosis. The timeline depends on the cancer’s details and the patient’s health.

Treatment Phase

Typical Timeline

Key Activities

Surgery

1-2 weeks post-diagnosis

Lumpectomy or mastectomy

Radiation Therapy

3-6 weeks post-surgery

Daily radiation sessions, Monday to Friday

Chemotherapy (if needed)

Variable, often after surgery

Cycles of chemotherapy, every 1-3 weeks

Post-Treatment Monitoring and Follow-Up

After treatment, patients start a follow-up phase. This includes regular check-ups and monitoring for recurrence. It’s key for early detection.

Follow-up care typically involves:

  • Regular mammograms
  • Physical examinations
  • Discussion of any symptoms or concerns
  • Potential additional tests (e.g., blood tests, imaging studies)

Understanding the treatment timeline is crucial for patients with early-stage breast cancer as it prepares them for what to expect and enhances their ability to make informed decisions. It aids in navigating their care and making informed decisions.

Radiation Therapy for Early Breast Cancer

Many patients with early breast cancer need radiation therapy as part of their treatment. This therapy uses high-energy particles or waves to kill cancer cells. It focuses on the area where the cancer is found.

When Radiation is Recommended

Radiation therapy is often needed after surgery, like lumpectomy. It helps get rid of any cancer cells left behind. This lowers the chance of cancer coming back. It’s also used for those who had mastectomy, if the cancer was big or spread to lymph nodes.

Choosing radiation therapy depends on the cancer’s stage, surgery type, and health. Our team carefully plans the best treatment for each patient.

Stage 1 Breast Cancer Radiation Side Effects

Radiation therapy can cause side effects. Common ones include feeling tired, skin changes, and breast swelling. Some might also feel pain or discomfort.

Side effects differ from person to person. We help our patients manage these effects to improve their daily life.

Side Effect

Description

Management Strategies

Fatigue

Feeling tired or weak

Rest, exercise, nutrition counseling

Skin Changes

Redness, itching, peeling

Topical creams, gentle skin care

Swelling

Breast swelling or tenderness

Compression garments, elevation

Managing Radiation Side Effects

It’s important to manage radiation side effects to keep patients’ quality of life good. We give advice on skin care, suggest exercises, and offer nutrition help to fight fatigue.

For severe side effects, we might need to do more. Our team closely watches patients and changes treatment plans as needed.

  • Follow a healthy diet rich in fruits, vegetables, and whole grains.
  • Stay hydrated by drinking plenty of water.
  • Engage in gentle exercises, such as yoga or walking, to maintain mobility and reduce fatigue.
  • Use topical creams or gels as recommended to soothe skin irritation.

Understanding radiation therapy and its side effects helps patients on their treatment journey. Our team is dedicated to giving full care and support during treatment.

When Is Mastectomy Required?

The need for mastectomy depends on the size and type of breast cancer.

Factors That Determine Mastectomy vs. Lumpectomy

Many things decide between mastectomy and lumpectomy. These include the tumor’s size, if there are many tumors, and the patient’s health and wishes.

We choose mastectomy for big tumors or when cancer is in many parts of the breast. This makes it hard to remove all cancer with a lumpectomy.

  • Tumor size and location
  • Presence of multiple tumors
  • Patient’s genetic predisposition (e.g., BRCA1 or BRCA2 mutations)
  • Previous radiation therapy to the breast or chest area

What Stage of Breast Cancer Requires a Mastectomy?

Mastectomy is often needed for more serious breast cancer stages or certain conditions.

Stage

Description

Treatment Considerations

Stage 0

Ductal carcinoma in situ (DCIS)

Lumpectomy or mastectomy, depending on the extent of DCIS

Stage I

Early-stage invasive cancer

Lumpectomy with radiation or mastectomy

Stage II-III

Locally advanced cancer

Mastectomy is often recommended, possibly with neoadjuvant chemotherapy

Reconstructive Options After Mastectomy

Choosing reconstruction after mastectomy is a personal choice. It depends on health, body type, and personal preferences.

We offer several options, including:

  • Implant reconstruction
  • Autologous tissue reconstruction (using the patient’s own tissue)
  • Combination of implant and autologous tissue reconstruction

Each option has its own benefits and things to consider. The right choice should be made after talking to a healthcare provider.

Challenging Breast Cancer Types: Triple-Negative and Inflammatory

The fight against breast cancer has grown, but some types, like triple-negative and inflammatory breast cancer, are tough to beat. These cancers have unique traits and don’t always respond well to treatments. This makes them harder to treat.

Why These Cancers Are More Difficult to Treat

Triple-negative breast cancer doesn’t have receptors for estrogen, progesterone, or HER2. This means it can’t be treated with hormone therapy or drugs targeting HER2. Inflammatory breast cancer is fast-growing and spreads quickly through the breast. It often causes skin changes and swelling.

Because of their aggressive nature, these cancers need strong treatments. For triple-negative breast cancer, chemotherapy is often the first line of defense. Inflammatory breast cancer might need a mix of chemotherapy, radiation, and surgery to treat.

Current Treatment Approaches

Doctors use a few main ways to treat these cancers:

  • Chemotherapy: To fight the cancer’s fast growth.
  • Surgery: To remove the tumor and affected tissue.
  • Radiation Therapy: To kill any cancer cells left behind.
  • Targeted Therapy: Sometimes used in clinical trials.

For inflammatory breast cancer, treatment starts with chemotherapy to shrink the tumor. Then, surgery and radiation therapy follow. Researchers are also looking into targeted therapy in clinical trials.

Ongoing Research and Emerging Therapies

Scientists are working hard to find better treatments for these cancers. New ideas include:

  1. Immunotherapy: Using the body’s immune system to fight cancer.
  2. PARP Inhibitors: A new option for those with BRCA mutations.
  3. Clinical Trials: Testing new combinations of treatments.

These new ideas give hope for better treatments for triple-negative and inflammatory breast cancer. As research keeps moving forward, we’ll likely see more effective treatments.

Disease Progression: How Long from Stage1 to Stage4 Cancer

The journey from Stage 1 to Stage 4 breast cancer is complex. It’s influenced by many factors. Knowing how cancer progresses helps patients and doctors make better treatment choices.

Factors Affecting Progression Rates

Several things affect how fast breast cancer grows. These include the cancer’s type and stage, hormone receptors, and the patient’s health. The type of breast cancer, like hormone receptor-positive or triple-negative, is key. Hormone receptor-positive cancers grow slower than triple-negative ones.

Other factors include the patient’s age, the cancer’s genetics, and if it’s in the lymph nodes. Early detection and treatment can change the disease’s course.

Typical Timelines Without Treatment

Without treatment, breast cancer’s progression from Stage 1 to Stage 4 varies. It usually takes years, but it depends on several factors. In some cases, it grows fast, while in others, it stays stable for a long time.

Breast cancer is different for everyone. Its growth is influenced by many factors. Knowing these factors helps predict progression and plan treatment.

How Treatment Interrupts Progression

Treatment is key to stopping breast cancer’s growth. Treatments like surgery, chemotherapy, and hormone therapy can slow or stop it. The right treatment depends on the cancer’s type, stage, and other factors.

Understanding treatment’s impact on cancer helps patients and doctors create a personalized plan. Early treatment and the right plan can improve survival and quality of life.

Conclusion: Is Breast Cancer Curable?

Breast cancer survival rates have greatly improved thanks to new medical technology and treatments. The reports that survival rates are high. For example, the 5-year survival rate for localized breast cancer is 100%.

Early detection and the right treatment can make many breast cancers curable. Finding cancer early is key. Places like Liv Hospital are leading the way in breast cancer care, showing the importance of quick and effective treatment.

Knowing about breast cancer survival rates helps patients and doctors make better choices. By focusing on early detection and tailored care, we can keep improving outcomes. This way, we’re moving closer to a future where breast cancer is curable for more people.

FAQ

What is the survival rate for hormone receptor-positive, HER2-negative breast cancer?

Hormone receptor-positive, HER2-negative breast cancer has a high survival rate. This is because it responds well to hormone therapy. Patients with this type of cancer often have better outcomes than others.

How is stage0 breast cancer treated?

Stage0 breast cancer, or ductal carcinoma in situ, is treated with surgery. This can be lumpectomy or mastectomy. Sometimes, radiation therapy follows. We tailor treatment plans to each patient’s needs.

What are the characteristics of stage1 breast cancer?

Stage1 breast cancer has a small tumor size, less than 2 cm, and no lymph node involvement. Early detection and treatment at this stage greatly improve outcomes.

How often should I undergo breast cancer screening?

Women over 40 should get annual mammograms. Your risk factors and screening schedule should be discussed with your doctor.

What are the common physical symptoms of breast cancer?

Symptoms include a new lump, changes in breast shape or size, and nipple discharge. If you notice anything unusual, seek medical attention.

What is invasive ductal carcinoma grade1, and what is its prognosis?

Invasive ductal carcinoma grade1 is a slow-growing cancer. Patients with this type have a good prognosis, mainly if caught early.

What is the typical treatment timeline for early-stage breast cancer?

Early-stage breast cancer treatment includes diagnosis, planning, surgery, and follow-up. We create personalized plans and support patients throughout.

When is radiation therapy recommended for breast cancer?

Radiation therapy is often needed after lumpectomy to lower recurrence risk. It’s also considered for certain risk factors or tumor characteristics.

What stage of breast cancer requires a mastectomy?

Mastectomy is considered for large tumors or when lumpectomy isn’t possible. The decision depends on tumor size, location, and patient preference.

How long does it take for breast cancer to progress from stage1 to stage4 without treatment?

Disease progression varies by individual factors like tumor biology and health. Some cancers progress quickly, while others grow slowly.

Is breast cancer curable?

Many breast cancers are curable with timely and effective treatment. Early detection and proper treatment are key to improving outcomes.

What are the treatment options for triple-negative breast cancer?

Triple-negative breast cancer is treated with surgery, chemotherapy, and radiation. We’re researching new therapies to improve treatment for this challenging type.

Can invasive ductal carcinoma be treated with hormone therapy?

Hormone receptor-positive invasive ductal carcinoma can be treated with hormone therapy. We choose the best treatment based on each patient’s tumor characteristics.

References

  1. National Cancer Institute (SEER). (n.d.). Female breast cancer subtypes (SEER Stat Facts). Retrieved from https://seer.cancer.gov/statfacts/html/breast-subtypes.html
  2. National Breast Cancer Foundation. (n.d.). Breast cancer facts & stats. Retrieved from https://www.nationalbreastcancer.org/breast-cancer-facts/
  3. Breast Cancer Research Foundation. (n.d.). Breast cancer survival rates. Retrieved from https://www.bcrf.org/about-breast-cancer/breast-cancer-survival-rates/
  4. Susan G. Komen. (n.d.). Understanding breast cancer survival rates. Retrieved from https://www.komen.org/breast-cancer/facts-statistics/breast-cancer-statistics/survival-rates/
  5. National Cancer Institute. (2024, December 11). Breast Cancer Treatment (PDQ®) – Patient Version. Retrieved from https://www.cancer.gov/types/breast/hp/breast-treatment-pdq

Trusted Worldwide
30
Years of
Experience
30 Years Badge

With patients from across the globe, we bring over three decades of medical

Prof. MD. Emre Merdan Fayda Prof. MD. Emre Merdan Fayda TEMP. Cancer
Patient Reviews
Reviews from 9,651
4,9

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Emir Çelik

Assoc. Prof. MD. Emir Çelik

MD. Edanur Tekcan Dinler

MD. Edanur Tekcan Dinler

Asst. Prof. MD. Beril Uğurnal

Asst. Prof. MD. Beril Uğurnal

Prof. MD. İsmet Alkış

Prof. MD. İsmet Alkış

Spec. Dt. Ecem Aytuna Yardım

Spec. Dt. Ecem Aytuna Yardım

Spec. MD.  AYNURE HEMIDOVA

Spec. MD. AYNURE HEMIDOVA

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Op. MD. Abdulkadir Tekin

Op. MD. Abdulkadir Tekin

Prof. MD. Serdar Kahraman

Prof. MD. Serdar Kahraman

Prof. MD. Selçuk Şahin

Prof. MD. Selçuk Şahin

Prof. MD. Süleyman Tevfik Ecder

Prof. MD. Süleyman Tevfik Ecder

Op. MD. Sevim Pırıl Karasu

Op. MD. Sevim Pırıl Karasu

Your Comparison List (you must select at least 2 packages)